ABIOMED Adds 3% in Pre-Market – Receives CE Mark for Impella RP April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Alex Hull ABIOMED Adds 3% in Pre-Market – Receives CE Mark for Impella RP.